Publications by authors named "Keisuke Ando"

Claim this Profile
E
Efficacy and safety of a reduced starting dose of cabozantinib (20 mg) plus nivolumab for renal cell carcinoma in real-world practice.
Tomokazu Sazuka, Yuri Watanabe, Fumiya Yokochi, Kohei Toma, Yusuke Onoda, Keisuke Ando

Jpn J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consecutive real-world treatment experience with a reduced starting dose of lenvatinib (14 mg) plus pembrolizumab for metastatic renal cell carcinoma.
Tomokazu Sazuka, Kentaro Murakami, Hidetaka Nihei, Yuki Iida, Kosuke Mikami, Keisuke Ando

Jpn J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.
Tomoki Shirafuji, Yasutaka Yamada, Kodai Sato, Zhao Xue, Takuya Tsujino, Keisuke Ando

BJU Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.
Yosuke Kinoshita, Yasutaka Yamada, Takuya Tsujino, Zhao Xue, Kodai Sato, Keisuke Ando

Jpn J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial report of prospective study of regional cooperation for imaging-based follow-up after curative renal cell carcinoma surgery.
Ryo Tsukamoto, Tomokazu Sazuka, Hiroaki Sato, Takayuki Arai, Manato Kanesaka, Keisuke Ando

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.
Maihulan Maimaiti, Shinichi Sakamoto, Masahiro Sugiura, Manato Kanesaka, Ayumi Fujimoto, Keisuke Ando

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning analysis for detecting late recurrence and loss to follow-up after renal cell carcinoma surgery.
Kodai Sato, Tomokazu Sazuka, Takayuki Arai, Hiroaki Sato, Manato Kanesaka, Keisuke Ando

BJUI Compass· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.
Shinpei Saito, Keisuke Ando, Shinichi Sakamoto, Minhui Xu, Yasutaka Yamada

Cancer Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Residual Urine Volume and Recurrence Among Patients at High Risk of Non-Muscle-Invasive Bladder Carcinoma With Versus Without Bacillus Calmette-Guérin Treatment.
Yuki Murakami, Tomokazu Sazuka, Ryo Tsukamoto, Hiroaki Sato, Keisuke Ando

Cureus· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer.
Shinichi Sakamoto, Keisuke Ando, Sangjon Pae, Xue Zhao, Kazuko Sakai

Anticancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.
Junryo Rii, Shinichi Sakamoto, Masahiro Sugiura, Manato Kanesaka, Ayumu Fujimoto, Keisuke Ando

Cancer Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.
Maihulan Maimaiti, Shinichi Sakamoto, Masahiro Sugiura, Manato Kanesaka, Ayumi Fujimoto, Keisuke Ando

Sci Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel.
Keisuke Ando, Shinichi Sakamoto, Shinpei Saito, Maihulan Maimaiti, Yusuke Imamura

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxel.
Keisuke Ando, Shinichi Sakamoto, Nobushige Takeshita, Ayumi Fujimoto, Maihulan Maimaiti

Prostate· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.
Maihulan Maimaiti, Shinichi Sakamoto, Yasutaka Yamada, Masahiro Sugiura, Junryo Rii, Keisuke Ando

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma.
Kosuke Higuchi, Shinichi Sakamoto, Keisuke Ando, Maihulan Maimaiti, Nobushige Takeshita

Sci Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nadir Testosterone after Long-Term Followup Predicts Prognosis in Patients with Prostate Cancer Treated with Combined Androgen Blockade.
Shuhei Kamada, Shinichi Sakamoto, Keisuke Ando, Ayumi Muroi, Miki Fuse

J Urol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image sensor pixel with on-chip high extinction ratio polarizer based on 65-nm standard CMOS technology.
Kiyotaka Sasagawa, Sanshiro Shishido, Keisuke Ando, Hitoshi Matsuoka, Toshihiko Noda

Opt Express· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis